A potential primary endpoint for clinical trials in glaucoma neuroprotection

De Moraes, C. G., Lane, K. J., Wang, X., & Liebmann, J. M. (2023). A potential primary endpoint for clinical trials in glaucoma neuroprotection. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-34009-x

Authors:

Carlos Gustavo De Moraes

Keith J. Lane

Xiao Wang

Jeffrey M. Liebmann

Affiliated Authors:

Carlos Gustavo De Moraes

Jeffrey M. Liebmann

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Ophthalmology

Subjects:

Neuroprotection (MeSH)

Glaucoma (MeSH)

Global Prevalence and Treatment of Glaucoma (OpenAlex Topic)

Age-Related Macular Degeneration Research (OpenAlex Topic)

Molecular Mechanisms of Retinal Degeneration and Regeneration (OpenAlex Topic)

elink

Publication Type:

Article

Unique ID:

10.1038/s41598-023-34009-x

PMID:

37130950

DOI:

10.1038/s41598-023-34009-x

Journal:

Scientific Reports

Publication Date:

2023-12-01

Data Source:

Scopus

Source Link:

View Scopus Record

View OpenAlex Record

View PubMed Record

Record Created:

Tuesday, July 30, 2024 - 13:38